Literature DB >> 22507970

Coronary artery disease: Risk models for revascularization--the search continues.

Seung-Jung Park, Cheol Whan Lee.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22507970     DOI： 10.1038/nrcardio.2012.57

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  6 in total

1.  Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry.

Authors:  William S Weintraub; Maria V Grau-Sepulveda; Jocelyn M Weiss; Elizabeth R Delong; Eric D Peterson; Sean M O'Brien; Paul Kolm; Lloyd W Klein; Richard E Shaw; Charles McKay; Laura L Ritzenthaler; Jeffrey J Popma; John C Messenger; David M Shahian; Frederick L Grover; John E Mayer; Kirk N Garratt; Issam D Moussa; Fred H Edwards; George D Dangas
Journal:  Circulation       Date:  2012-02-23       Impact factor: 29.690

2.  Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study).

Authors:  David M Shahian; Sean M O'Brien; Shubin Sheng; Frederick L Grover; John E Mayer; Jeffrey P Jacobs; Jocelyn M Weiss; Elizabeth R Delong; Eric D Peterson; William S Weintraub; Maria V Grau-Sepulveda; Lloyd W Klein; Richard E Shaw; Kirk N Garratt; Issam D Moussa; Cynthia M Shewan; George D Dangas; Fred H Edwards
Journal:  Circulation       Date:  2012-02-23       Impact factor: 29.690

3.  Comparative effectiveness of revascularization strategies.

Authors:  William S Weintraub; Maria V Grau-Sepulveda; Jocelyn M Weiss; Sean M O'Brien; Eric D Peterson; Paul Kolm; Zugui Zhang; Lloyd W Klein; Richard E Shaw; Charles McKay; Laura L Ritzenthaler; Jeffrey J Popma; John C Messenger; David M Shahian; Frederick L Grover; John E Mayer; Cynthia M Shewan; Kirk N Garratt; Issam D Moussa; George D Dangas; Fred H Edwards
Journal:  N Engl J Med       Date:  2012-03-27       Impact factor: 91.245

4.  Randomized trial of stents versus bypass surgery for left main coronary artery disease.

Authors:  Seung-Jung Park; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Jung-Min Ahn; Hae Geun Song; Jong-Young Lee; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Cheol-Hyun Chung; Jae-Won Lee; Do-Sun Lim; Seung-Woon Rha; Sang-Gon Lee; Hyeon-Cheol Gwon; Hyo-Soo Kim; In-Ho Chae; Yangsoo Jang; Myung-Ho Jeong; Seung-Jea Tahk; Ki Bae Seung
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

5.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

6.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

Authors:  Mark A Hlatky; Derek B Boothroyd; Dena M Bravata; Eric Boersma; Jean Booth; Maria M Brooks; Didier Carrié; Tim C Clayton; Nicolas Danchin; Marcus Flather; Christian W Hamm; Whady A Hueb; Jan Kähler; Sheryl F Kelsey; Spencer B King; Andrzej S Kosinski; Neuza Lopes; Kathryn M McDonald; Alfredo Rodriguez; Patrick Serruys; Ulrich Sigwart; Rodney H Stables; Douglas K Owens; Stuart J Pocock
Journal:  Lancet       Date:  2009-03-19       Impact factor: 79.321
  6 in total
  1 in total

1.  Impact of left main coronary artery disease on long-term mortality in patients undergoing drug-eluting stent implantation.

Authors:  Se Hun Kang; Cheol Whan Lee; Seunghee Baek; Pil Hyung Lee; Jung-Min Ahn; Duk-Woo Park; Soo-Jin Kang; Seung-Whan Lee; Young-Hak Kim; Seong-Wook Park; Seung-Jung Park
Journal:  Clin Res Cardiol       Date:  2017-08-03       Impact factor: 5.460
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.